November 16, 2023
Chuikyo OKs Listing of Wegovy at General Assembly Meeting on Nov. 15 Novo Nordisk’s GLP-1 receptor agonist Wegovy (semaglutide) is finally joining the NHI price list on November 22 after skipping two rounds of listing since it scored regulatory approval...read more